Bayer to give milestone payment to Ranbaxy for outlicensed drug
Ranbaxy Laboratories will receive $6-8 million from Bayer AG before the end of the year as a milestone payment for a drug it has licensed to the Geman, firm, an industry sources said.
Ranbaxy Laboratories will receive $6-8 million from Bayer AG before the end of the year as a milestone payment for a drug it has licensed to the Geman, firm, an industry sources said.